Lazaga, Conchita T.

HRN: 24-01-91  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/01/2023
CIPROFLOXACIN 500MG (TAB)
11/01/2023
11/08/2023
PO
500mg
BID
Infectious Diarrhea
Checking Final Appropriateness 
11/02/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/02/2023
11/08/2023
IV
500mg
Q8
Amoebiasis
Checking Final Appropriateness 
11/03/2023
AMOXICILLIN 500MG CAPSULE (CAP)
11/03/2023
11/16/2023
PO
1gm
BID
H Pylori Infection
Checking Final Appropriateness 
11/05/2023
METRONIDAZOLE 500MG (TAB)
11/05/2023
11/11/2023
ORAL
500mg
Tid
Ameobiasis
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: